Erratic market delays Transoma IPO
This article was originally published in Clinica
Executive Summary
Implantable wireless diagnostics specialist Transoma Medical has said it is postponing its IPO due to the current unpredictable economic climate in the US. The Minnesota-based firm told the Minneapolis/St Paul Business Journal that it still plans to go ahead with the IPO on the Nasdaq Stock Exchange. The offering was originally filed in October 2007 and is expected to raise $75m (see Clinica No 1278, p 8). Transoma was planning to use the funding to develop chronic cardiovascular disease technology and its Sleuth implantable ECG monitoring system. The company will be looking to avoid the fluctuating market conditions that have affected Enteromedics, another St Paul-based company that recently floated on the Nasdaq. Enteromedics, a neuroblocking technology company also based in St Paul, saw its share price fall by 11% from $8.73 per share to $7.76 during the last week.
You may also be interested in...
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.